Beam Therapeutics Inc.
NASDAQ:BEAM
27.5 (USD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 14.269 | 11.772 | 7.41 | 316.192 | 17.193 | 20.116 | 24.208 | 20.037 | 15.799 | 16.652 | 8.432 | 51.069 | 0.763 | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 5.475 | 5.576 | 5.431 | 5.362 | 7.475 | 7.291 | 7.001 | 6.187 | 85.287 | 5.515 | 5.259 | 5.018 | 54.623 | 45.577 | 190.106 | 38.028 | 27.826 | 19.354 | 21.549 | 19.131 | 11.368 | 11.212 | 8.672 | 8.849 | 6.127 | 6.502 | 6.502 |
| Gross Profit
| 8.794 | 6.196 | 1.979 | 310.83 | 9.718 | 12.825 | 17.207 | 13.85 | -69.488 | 11.137 | 3.173 | 46.051 | -53.86 | -45.571 | -190.1 | -38.022 | -27.82 | -19.348 | -21.543 | -19.125 | -11.362 | -11.206 | -8.672 | -8.849 | -6.127 | -6.502 | -6.502 |
| Gross Profit Ratio
| 0.616 | 0.526 | 0.267 | 0.983 | 0.565 | 0.638 | 0.711 | 0.691 | -4.398 | 0.669 | 0.376 | 0.902 | -70.59 | -7,595.167 | -31,683.333 | -6,337 | -4,636.667 | -3,224.667 | -3,590.5 | -3,187.5 | -1,893.667 | -1,867.667 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 94.258 | 87.041 | 84.818 | 140.077 | 100.05 | 97.608 | 99.646 | 86.341 | 85.287 | 74.556 | 65.41 | 96.781 | 54.623 | 45.577 | 190.106 | 32.451 | 29.825 | 19.354 | 21.549 | 20.217 | 12.543 | 12.68 | 9.179 | 9.852 | 9.854 | 7.084 | 7.084 |
| General & Administrative Expenses
| 26.515 | 29.626 | 26.724 | 43.257 | 25.41 | 24.656 | 23.49 | 22.681 | 21.815 | 24.062 | 19.247 | 17.772 | 15.774 | 13.403 | 10.273 | 8.354 | 7.502 | 6.937 | 6.812 | 6.16 | 5.487 | 4.977 | 3.929 | 3.711 | 2.834 | 2.662 | 2.662 |
| Selling & Marketing Expenses
| 0 | -5.576 | -5.431 | -5.362 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 26.515 | 24.05 | 21.293 | 37.895 | 25.41 | 24.656 | 23.49 | 22.681 | 21.815 | 24.062 | 19.247 | 17.772 | 15.774 | 13.403 | 10.273 | 8.354 | 7.502 | 6.937 | 6.812 | 6.16 | 5.487 | 4.977 | 3.929 | 3.711 | 2.834 | 2.662 | 2.662 |
| Other Expenses
| 0 | -87.041 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.305 | 0 | 0 | 0 | 0 | -0.064 | -0.002 | 0 | 0 | -5.648 | -4.004 | 0 | 0 |
| Operating Expenses
| 120.773 | 111.091 | 106.111 | 177.972 | 125.46 | 122.264 | 123.136 | 109.022 | 107.102 | 98.618 | 84.657 | 114.553 | 70.397 | 58.98 | 200.379 | 40.805 | 37.327 | 26.291 | 28.361 | 26.377 | 18.03 | 17.657 | 13.108 | 13.563 | 12.688 | 3.695 | 3.695 |
| Operating Income
| -106.504 | -104.895 | -104.132 | 132.858 | -108.267 | -102.148 | -98.928 | -88.985 | -91.303 | -81.966 | -76.225 | -63.484 | -69.634 | -58.974 | -200.373 | -40.799 | -37.321 | -26.285 | -28.355 | -26.371 | -18.024 | -17.651 | -13.108 | -13.563 | -12.688 | -9.745 | -9.745 |
| Operating Income Ratio
| -7.464 | -8.911 | -14.053 | 0.42 | -6.297 | -5.078 | -4.087 | -4.441 | -5.779 | -4.922 | -9.04 | -1.243 | -91.263 | -9,829 | -33,395.5 | -6,799.833 | -6,220.167 | -4,380.833 | -4,725.833 | -4,395.167 | -3,004 | -2,941.833 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 9.836 | 13.883 | 5.463 | 11.305 | 12.179 | 19.372 | 2.468 | 51.636 | 9.638 | 10.016 | 7.011 | -1.223 | 41.516 | -17.279 | -1.187 | -54.665 | 2.869 | -7.933 | -2.103 | -1.479 | -0.981 | -0.21 | -0.502 | -11.631 | -58.463 | -0.452 | -0.452 |
| Income Before Tax
| -96.668 | -91.012 | -98.669 | 144.163 | -96.088 | -82.776 | -96.46 | -37.349 | -107.165 | -71.95 | -69.214 | -64.707 | -28.118 | -76.253 | -201.56 | -95.464 | -34.452 | -34.218 | -30.458 | -27.85 | -19.005 | -17.861 | -13.61 | -25.194 | -71.151 | -10.197 | -10.197 |
| Income Before Tax Ratio
| -6.775 | -7.731 | -13.316 | 0.456 | -5.589 | -4.115 | -3.985 | -1.864 | -6.783 | -4.321 | -8.208 | -1.267 | -36.852 | -12,708.833 | -33,593.333 | -15,910.667 | -5,742 | -5,703 | -5,076.333 | -4,641.667 | -3,167.5 | -2,976.833 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0.039 | 5.388 | 1.366 | -17.366 | -24.188 | -12.429 | 1 | 2.41 | -23.45 | -14.022 | -0.134 | -41.516 | 17.279 | 0.882 | 54.665 | -4.087 | 7.933 | 2.103 | 0.055 | 0.981 | 0.21 | 0.502 | 65.349 | -6.258 | 0.112 | 0.112 |
| Net Income
| -96.668 | -91.051 | -98.669 | 142.797 | -96.088 | -82.776 | -84.031 | -38.349 | -109.575 | -48.5 | -55.192 | -64.573 | -28.118 | -76.253 | -201.56 | -95.464 | -34.452 | -34.218 | -30.458 | -27.85 | -19.005 | -17.861 | -13.61 | -25.194 | -69.8 | -10.309 | -10.309 |
| Net Income Ratio
| -6.775 | -7.735 | -13.316 | 0.452 | -5.589 | -4.115 | -3.471 | -1.914 | -6.936 | -2.913 | -6.546 | -1.264 | -36.852 | -12,708.833 | -33,593.333 | -15,910.667 | -5,742 | -5,703 | -5,076.333 | -4,641.667 | -3,167.5 | -2,976.833 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.17 | -1.11 | -1.21 | 1.77 | -1.22 | -1.08 | -1.16 | -0.54 | -1.56 | -0.69 | -0.8 | -0.95 | -0.42 | -1.23 | -3.35 | -1.59 | -0.69 | -0.69 | -0.99 | -0.91 | -0.54 | -0.51 | -0.39 | -0.72 | -1.99 | -8.11 | -8.11 |
| EPS Diluted
| -1.17 | -1.11 | -1.21 | 1.73 | -1.22 | -1.08 | -1.16 | -0.54 | -1.56 | -0.69 | -0.8 | -0.95 | -0.42 | -1.23 | -3.35 | -1.59 | -0.69 | -0.69 | -0.99 | -0.91 | -0.54 | -0.51 | -0.39 | -0.72 | -1.99 | -8.11 | -8.11 |
| EBITDA
| -91.193 | -99.319 | -98.701 | 138.22 | -103.08 | -97.332 | -94.281 | -85.041 | -87.83 | -78.548 | -72.913 | -59.689 | -67.884 | -57.305 | -197.801 | -39.527 | -36.103 | -25.14 | -27.255 | -25.844 | -17.116 | -16.793 | -12.373 | -24.661 | -71.087 | -9.719 | -9.719 |
| EBITDA Ratio
| -6.391 | -8.437 | -13.32 | 0.437 | -6.267 | -5.447 | -3.777 | -6.638 | -6.074 | -5.4 | -9.402 | -1.218 | -143.37 | -6,679.667 | -32,845.833 | 2,528.833 | -6,670.167 | -2,740 | -4,092.5 | -4,154.833 | -2,586 | -2,632.167 | 0 | 0 | 0 | 0 | 0 |